4//SEC Filing
VANLENT ANNE 4
Accession 0000950170-25-086110
CIK 0001563880other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:00 PM ET
Size
5.4 KB
Accession
0000950170-25-086110
Insider Transaction Report
Form 4
VANLENT ANNE
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2025-06-11+45,000→ 45,000 totalExercise: $6.25Exp: 2035-06-10→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 11, 2025. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001229243
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:00 PM ET
- Size
- 5.4 KB